Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2026)
Abeona Therapeutics' (ABEO) quarterly Interest Income - Net came in at -$3000.0 in Q1 2026, up 94.44% year-on-year from -$1542.9 in Q1 2025, and down 100.12% quarter-over-quarter from $2.5 million in Q4 2025.
Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Income - Net history runs 6 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- On a quarterly basis, Interest Income - Net rose 94.44% year-over-year to -$3000.0 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 149.93% increase from a year earlier, with the FY2025 full-year figure at -$69.4 million, down 182642.11% from the prior year.
- Interest Income - Net fell to -$3000.0 in Q1 2026 per ABEO's latest filing, from $2.5 million in the prior quarter.
- Across five years, Interest Income - Net topped out at $2.5 million in Q4 2025 and bottomed at -$11.5 million in Q1 2022.
- The 5-year median for Interest Income - Net is -$374000.0 (2023), against an average of -$2.1 million.
- Across the five-year window, Interest Income - Net plunged 444.14% in 2024 and jumped 4396.61% in 2025, its largest moves.
- Year by year, Interest Income - Net stood at $150000.0 in 2022, then surged by 322.67% to $634000.0 in 2023, then sank by 109.31% to -$59000.0 in 2024, then soared by 4396.61% to $2.5 million in 2025, then sank by 100.12% to -$3000.0 in 2026.
- Per Business Quant, the three latest ABEO Interest Income - Net figures stand at -$3000.0 (Q1 2026), $2.5 million (Q4 2025), and $245000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -17.04 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 2.54 Mn |
| Sep 30, 2025 | 245,000.00 |
| Jun 30, 2025 | -302,000.00 |
| Mar 31, 2025 | -54,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | -4.23 Mn |
| Jun 30, 2024 | -616,000.00 |
| Mar 31, 2024 | -1.15 Mn |
| Dec 31, 2023 | 634,000.00 |
| Sep 30, 2023 | -777,000.00 |
| Jun 30, 2023 | -374,000.00 |
| Mar 31, 2023 | -8.59 Mn |
| Dec 31, 2022 | 150,000.00 |
| Sep 30, 2022 | -1.56 Mn |
| Jun 30, 2022 | -10.65 Mn |
| Mar 31, 2022 | -11.50 Mn |
| Dec 31, 2021 | 3.21 Mn |
| Sep 30, 2021 | -909,000.00 |